BioSpace News Archive

Business

Arrowhead Pharmaceuticals Reports Inducement Grants To Six New Employees under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. announced that as an inducement to entering into employment with the Company, on March 16, 2018, the Board of Directors approved “inducement” grants to six new employees.

March 20, 2018
·
1 min read
Business

Brammer Bio Expands Leadership Team for Commercial Readiness

Brammer Bio announces recent leadership appointments to support the growth of the organization.

March 20, 2018
·
2 min read
Oxford Nanopore Announces £100 Million ($140M) Fundraising from Global Investors

Oxford Nanopore Technologies Ltd has raised £100M ($140M) in new investment.

March 20, 2018
·
4 min read
Pharm Country

Supplemental Health Care’s Travel Nursing Division and Local Allied and Nursing Office Named “Best Place to Work”

Supplemental Health Care is proud to earn the “Best Place to Work” award in the large-sized company category by Buffalo Business First, a leading business publication in the region.

March 20, 2018
·
2 min read
Drug Development

Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System

Boston Scientific Corporation announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain.

March 20, 2018
·
2 min read
Genetown

As Marketplace Competition Heats Up for Clinical Trial Concierge Services, BBK Worldwide Releases Key Data from Multiple Years in the Field

BBK Worldwide (BBK), an industry leader in the clinical trial patient experience and engagement technologies, releases key performance metrics on its concierge services, revealing the significant impact these site- and patient-centric programs have on global clinical trial recruitment and engagement.

March 20, 2018
·
4 min read
BioCapital

New Kalorama Report Identifies 27 Market Disruptors in Healthcare

Trump Administration health policies in the U.S., Brexit and austerity in Europe, heavy M&A activity and the targeting of healthcare by Amazon and Apple is adding up to an “Era of Uncertainty” in healthcare, according to Kalorama Information.

March 20, 2018
·
3 min read
Business

Bicycle Therapeutics Promotes Michael Skynner, Ph.D., to Chief Operating Officer

Dr. Skynner has served as Bicycle’s Vice President of Operations and Discovery since January 2016.

March 20, 2018
·
3 min read
Genetown

Science Magazine Recognizes Frequency Therapeutics’ PCA Regeneration Technology as a Breakthrough in Regenerative Medicine

Frequency Co-founder Will McLean, Ph.D., Named a Finalist Awardee for the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy

March 20, 2018
·
3 min read
Biotech Bay

Varian-Equipped St. Petersburg Proton Therapy Center Completes First Patient Treatment

The patient was treated for a brain tumor at Russia’s first dedicated proton therapy treatment center.

March 20, 2018
·
2 min read